EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance

Lin Zhao iD, Haibo Han, Xuantong Zhou, Tongyang Gong, Yuge Zhu, Bufan Xiao, Shuchang Liu, Wei Zhao iD, Nan Wu iD

International Journal of Molecular Sciences · 14.05.2025 · 26 (10) · 4685

DOI: 10.3390/ijms26104685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.05.2025. Verfasst von Lin Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hosp…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Heme, Machine Learning, Adenocarcinoma of Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project of the Ministry of Science and Technology of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) is a leading cause of cancer-related mortality, with heme metabolism playing a critical role in tumor progression and treatment resistance. This study investigates the clinical implications of heme metabolism in LUAD, focusing on its link to ferroptosis and drug sensitivity. Using multi-omics data from TCGA-LUAD, GEO databases, and a single-cell RNA-seq cohort, we identified two molecular subtypes based on heme metabolism-related genes. We further developed a prognostic panel, termed the heme metabolism risk score (HMRS), using LASSO and multivariate Cox regression analyses. The HMRS panel effectively stratified patients into high- and low-risk groups, with high-risk patients showing enhanced tumor proliferation, suppressed ferroptosis, and resistance to chemotherapy. Single-cell analysis revealed elevated heme metabolism risk in epithelial cells correlated with tumor progression. Drug sensitivity predictions were validated in platinum-based chemotherapy cohorts, confirming HMRS as a robust prognostic tool. ABCC2 was identified as a key regulator of ferroptosis and cisplatin resistance, with in vitro experiments demonstrating that ABCC2 knockdown enhanced cisplatin-induced ferroptosis. These findings highlight HMRS as a critical tool for patient stratification and ABCC2 as a promising therapeutic target to overcome cisplatin resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmHemeMachine LearningAdenocarcinoma of LungLung NeoplasmsTranscriptomeHumansSingle-Cell AnalysisFerroptosisMultidrug Resistance-Associated Protein 2CisplatinGene Expression Regulation, NeoplasticPrognosisATP-Binding Cassette, Sub-Family C ProteinsCell Line, TumorGene Expression ProfilingAntineoplastic AgentsFemale

Stichwörter der Autor:innen

chemotherapy resistanceferroptosisheme metabolismlung adenocarcinomaprecision medicineprognosis

Substanzen

HemeMultidrug Resistance-Associated Protein 2CisplatinATP-Binding Cassette, Sub-Family C ProteinsAntineoplastic AgentsABCC2 protein, human

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Clinical Laboratory, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • State Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing 100142, China.

ORCID-Profile: Lin Zhao, Wei Zhao, Nan Wu

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Major Project of the Ministry of Science and Technology of China
  • National Key R&D Program of China
  • Capital's funds for health improvement and research
  • Beijing Natural Science Foundation
  • National Ten-thousand Talent Program, the Noncommunicable Chronic Diseases-National Sci-ence and Technology Major Project
  • Foundation of China Association for Promotion of Health Science and Technology
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Zhao, L., Han, H., Zhou, X., Gong, T., Zhu, Y., Xiao, B., Liu, S., Zhao, W., & Wu, N. (2025). Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance. International Journal of Molecular Sciences, 26(10), 4685. https://doi.org/10.3390/ijms26104685

Vancouver

Zhao L, Han H, Zhou X, Gong T, Zhu Y, Xiao B, et al. Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance. International Journal of Molecular Sciences. 2025;26(10):4685. doi:10.3390/ijms26104685

BibTeX
@article{Zhao2025,
  author = {Zhao, Lin and Han, Haibo and Zhou, Xuantong and Gong, Tongyang and Zhu, Yuge and Xiao, Bufan and Liu, Shuchang and Zhao, Wei and Wu, Nan},
  title = {Integrating Bulk and Single-Cell Transcriptomics with Machine Learning Reveals a Heme Metabolism-Based Panel for Lung Adenocarcinoma Chemotherapy Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {10},
  pages = {4685},
  doi = {10.3390/ijms26104685}
}
Kostenlos starten →